Literature DB >> 1655467

A functional complex is formed in human T lymphocytes between the protein tyrosine phosphatase CD45, the protein tyrosine kinase p56lck and pp32, a possible common substrate.

B Schraven1, H Kirchgessner, B Gaber, Y Samstag, S Meuer.   

Abstract

In vitro protein kinase assays of CD45 immunoprecipitates prepared from digitonin lysates of resting human T lymphocytes resulted in exclusive tyrosine phosphorylation of a 32-kDa protein (pp32). Reprecipitation of the in vitro phosphorylated proteins and Western blot analysis of whole CD45 immunoprecipitates employing antisera specifically directed at different protein tyrosine kinases demonstrated that the p56lck protein tyrosine kinase was responsible for in vitro phosphorylation of pp32. Since in vitro kinase assays of p56lck immunoprecipitates also resulted in phosphorylation of pp32, the present data strongly suggest that a functional complex is formed between CD45, p56lck and pp32. Such a notion is supported by the findings that phosphorylation of pp32 by p56lck correlated with expression of the CD45 molecules and that in vitro phosphorylated pp32 was completely dephosphorylated by purified CD45.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655467     DOI: 10.1002/eji.1830211025

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.

Authors:  A D Beyers; L L Spruyt; A F Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase.

Authors:  C- L Yu; H-S Yu; K-H Sun; S-C Hsieh; C-Y Tsai
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 3.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

4.  Protein-tyrosine phosphatase activity of CD45 is activated by sequential phosphorylation by two kinases.

Authors:  D R Stover; K A Walsh
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Herpesvirus saimiri Tip-484 membrane protein markedly increases p56lck activity in T cells.

Authors:  T Lund; M M Medveczky; P G Medveczky
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  SKAP55 coupled with CD45 positively regulates T-cell receptor-mediated gene transcription.

Authors:  Liangtang Wu; Jun Fu; Shi-Hsiang Shen
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

7.  Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase.

Authors:  M Autero; J Saharinen; T Pessa-Morikawa; M Soula-Rothhut; C Oetken; M Gassmann; M Bergman; K Alitalo; P Burn; C G Gahmberg
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in class II major histocompatibility complex-restricted antigen-specific T helper clones. T cell receptor/CD3 complex transmits CD4-dependent and CD4-independent signals.

Authors:  N Oyaizu; N Chirmule; S Pahwa
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

9.  Evidence for an association of CD45 with 32,000-33,000 MW phosphoproteins on murine T and B lymphocytes.

Authors:  J G Altin; E B Pagler; C R Parish
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

10.  The unique amino-terminal domain of p56lck regulates interactions with tyrosine protein phosphatases in T lymphocytes.

Authors:  F G Gervais; A Veillette
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.